Abstract: Described herein are AAV vector production systems and HSV-helper systems. Also described herein are engineered cells and kits comprising an AAV vector production system and/or an HSV-helper system and methods of using the same for AAV vector production.
Type:
Application
Filed:
November 9, 2022
Publication date:
January 9, 2025
Applicant:
ASIMOV INC.
Inventors:
Christopher S. Stach, Alec A.K. Nielsen
Abstract: Described herein are modified bacteriophage serine integrases that function in mammalian cells. Also described herein are landing pad architectures. Engineered cells comprising these integrases and landing pads are also described, which facilitate site-specific genomic integration of pay load molecules.
Type:
Application
Filed:
October 13, 2022
Publication date:
December 12, 2024
Applicant:
Asimov Inc.
Inventors:
Michael T. Leonard, Jeremy J. Gam, Christopher S. Stach, Alec A.K. Nielsen
Abstract: Described herein are viral vector production systems and engineered cells for viral vector production. Also described herein are methods of using the engineered cells to produce viral vectors.
Type:
Application
Filed:
May 17, 2022
Publication date:
August 1, 2024
Applicant:
Asimov Inc.
Inventors:
Jeremy J. Gam, Christopher S. Stach, Alec A.K. Nielsen
Abstract: Disclosed herein are cell genetically engineered cell for AAV production. The genetically engineered cell comprises molecular systems for temporal control of expression of genes required for AAV production. Also disclosed herein are methods of using genetically engineered cells for AAV production.
Type:
Application
Filed:
May 6, 2022
Publication date:
July 25, 2024
Applicant:
Asimov Inc.
Inventors:
Jeremy J. Gam, Brianna E.K. Jayanthi, Michael T. Leonard, Alec A.K. Nielsen
Abstract: Described herein are lentiviral vector production systems. Also described herein are engineered cells and kits comprising a lentiviral vector production system and methods of using the same for lentiviral vector production.
Abstract: Disclosed herein are compositions of destination and entry vectors. Also disclosed herein are the use of destination and entry vectors in methylation-obstructed assembly reactions, wherein the assembled sequences may be used as entry vectors in subsequent assembly reactions.
Type:
Application
Filed:
January 7, 2020
Publication date:
March 24, 2022
Applicant:
Asimov, Inc.
Inventors:
Alec A.K. Nielsen, Yekaterina Tarasova, Amber Marie Delhagen
Abstract: Disclosed herein are chimeric receptors and precursors, chimeric antigen receptors and precursors, universal chimeric receptor cell precursors, chimeric antigen receptor T cells, and methods of constructing and using the same.